S. Kobayashi et al., The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer, TOH J EX ME, 189(1), 1999, pp. 37-49
Neuron-specific enolase (NSE) and carcinoembryonic antigen (CEA) levels in
the culture supernatant of the 65 pulmonary carcinoma cell lines: Small cel
l lung cancer (SCLC!) 18, large cell carcinoma 14, squamous cell carcinoma
14, adenocarcinoma 14 and adenosquamous cell carcinoma 5, were measured by
a radioimmunoassay (RIA). The mean value of NSE was 30.8+/-22.4 ng/ml and 9
.2+/-8.7 ng/ml in SCLC and non-SCLC!, respectively. The mean value of CEA m
as 15.1+/-20.9 ng/ml and 26.6+/-72.3 ng/ml in SCLC and non-SCLC, respective
ly. A significant difference in NSE levels was obtained between SCLC! cell
lines and non-SCLC cell lines. In SCLC cell lines, a significant inverse pr
oportional correlation was observed between NSE and CEA levels. The CEA pro
duction tended to be higher in cells with low levels of NSE than in those w
ith high NSE production. With respect to correlation between marker product
ion and growth characteristics of SCLC cells in vitro, significantly higher
NSE and lower CEA levels mere found in cells growing with floating colony
or neurite like characteristics (classic cell type) than those in cells wit
h epithelial or intermediate growth characteristics (variant cell type). A
significant positive correlation between NSE levels and the survival period
s was found in follow-up studies of 10 patients who underwent surgery with
complete resection of the primary tumor. All of 4 long term survivors over
3 years after surgery had significantly high NSE and relatively low CEA pro
ducing tumors. The relationship of these markers to clinical status of the
patient suggests that an analysis for correlation of NSE and CEA levels in
SCLC patients may be useful to discriminate between a pure neuroendocrine S
CLC tumor and a mined small cell/large cell tumor, and in monitoring therap
eutic effect and prognosis of each patient.